Economy/Home · Economy

[Breaking] Lunit Shares Surge Over 10%... VI Triggered on NXT, Recovering 15,000-Won Level After Two Days of Decline

Lunit (328130) posted a double-digit surge early in the trading session on the 13rd, breaking away from a two-day losing streak. Attention is focused on the direction of its share price. As of 9:22 a.m. on the 13th, Lunit was trading at 15,160 won on the KOSDAQ market, up 1,440 won (10.50%) from th

Oseong Kwon
Staff Reporter
4 min read
[Breaking] Lunit Shares Surge Over 10%... VI Triggered on NXT, Recovering 15,000-Won Level After Two Days of Decline
CBC News

Lunit (328130) posted a double-digit surge early in the trading session on the 13rd, breaking away from a two-day losing streak. Attention is focused on the direction of its share price.

As of 9:22 a.m. on the 13th, Lunit was trading at 15,160 won on the KOSDAQ market, up 1,440 won (10.50%) from the previous day. Lunit had fallen for two consecutive sessions on the 11th and 12th, showing a weak trend, but it staged a strong rebound early in the session that day, recovering the 15,000-won level.

Notably, a volatility interruption (VI) was triggered for Lunit on the NEXTRADE (NXT) market as a static VI at 9:21:21 a.m. that day.

However, given the sharp early-session rally, investors should keep in mind the possibility of future price fluctuations. As this rebound comes after two straight days of declines, whether the upward trend can be sustained is drawing attention. Key points to watch are whether the stock can hold the 15,000-won level and whether it can extend its intraday gains further.

Lunit is a company that develops solutions for cancer diagnosis and treatment based on medical artificial intelligence (AI) technology. With recent news related to its overseas market expansion, attention is gathering around its future business performance. On the 10th, Lunit announced that it would supply its AI image analysis solution to the Health Affairs Department of the Saudi Arabian Ministry of National Guard.

Attention is now on whether Lunit, riding the sharp early-session surge, can sustain its rebound and move past two days of weakness.

[※ This article is for investment reference purposes only and does not recommend buying or selling any specific stock. The final judgment and responsibility for investments rest with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.